{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:35:25Z","timestamp":1793885725546,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jtct.2026.06.046","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:45:20Z","timestamp":1782517520000},"page":"1457.e1-1457.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["International Survey and Next-Generation Sequencing-Based Indel Chimerism Detection of Human Leukocyte Antigens Loss in Relapsed Haploidentical and Mismatched Unrelated Donor Transplant Recipients"],"prefix":"10.1016","volume":"32","author":[{"given":"Nihar","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn\u00e9a","family":"Pettersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-8018","authenticated-orcid":false,"given":"Jeffrey","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Uhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-6644","authenticated-orcid":false,"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtct.2026.06.046_bib0001","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","article-title":"One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation","volume":"49","author":"Thomas","year":"1977","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.jtct.2026.06.046_bib0002","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jtct.2026.06.046_bib0003","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bmt.1701064","article-title":"Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia","volume":"21","author":"Passweg","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.06.046_bib0004","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2026.06.046_bib0005","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/bmt.2016.167","article-title":"Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT","volume":"51","author":"Tsirigotis","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.06.046_bib0006","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1111\/bjh.70124","article-title":"A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation","volume":"207","author":"Desai","year":"2025","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.jtct.2026.06.046_bib0007","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/bmt.2016.167","article-title":"Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT","volume":"51","author":"Tsirigotis","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.06.046_bib0008","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41409-025-02524-2","article-title":"The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT","volume":"60","author":"Passweg","year":"2025","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2026.06.046_bib0009","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood-2018-10-846824","article-title":"Mechanisms of immune escape after allogeneic hematopoietic cell transplantation","volume":"133","author":"Zeiser","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2026.06.046_bib0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMoa0811036","article-title":"Loss of mismatched HLA in leukemia after stem-cell transplantation","volume":"361","author":"Vago","year":"2009","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.jtct.2026.06.046_bib0011","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1182\/blood-2012-02-411686","article-title":"Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT","volume":"119","author":"Toffalori","year":"2012","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.jtct.2026.06.046_bib0012","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood.2024025705","article-title":"How I treat AML relapse after allogeneic HSCT","volume":"145","author":"Gooptu","year":"2025","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.06.046_bib0013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/ejh.12322","article-title":"Experts\u2019 considerations on HLA-haploidentical stem cell transplantation","volume":"93","author":"Patriarca","year":"2014","journal-title":"Eur J Haematol"},{"issue":"10","key":"10.1016\/j.jtct.2026.06.046_bib0014","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood-2017-05-784306","article-title":"A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT","volume":"130","author":"Ahci","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.06.046_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1603188","article-title":"Interpreting immune evasion: a novel assay for HLA loss detection","volume":"16","author":"Pettersson","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jtct.2026.06.046_bib0016","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ajh.25087","article-title":"Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study","volume":"93","author":"Li","year":"2018","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.jtct.2026.06.046_bib0017","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jamaoncol.2018.2091","article-title":"Association of second allogeneic hematopoietic cell transplant vs donor lymphocyte infusion with overall survival in patients with acute myeloid leukemia relapse","volume":"4","author":"Kharfan-Dabaja","year":"2018","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2026.06.046_bib0018","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/j.bbmt.2009.10.023","article-title":"Relapse after allogeneic hematopoietic cell therapy","volume":"16","author":"van den Brink","year":"2010","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2026.06.046_bib0019","doi-asserted-by":"crossref","first-page":"767.e1","DOI":"10.1016\/j.jtct.2022.08.008","article-title":"Efficacy of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia: results of a systematic review and meta-analysis","volume":"28","author":"Kharfan-Dabaja","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.jtct.2026.06.046_bib0020","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/bmt.2015.186","article-title":"Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT","volume":"50","author":"Ruutu","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"26","key":"10.1016\/j.jtct.2026.06.046_bib0021","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1200\/JCO.2012.44.7961","article-title":"Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change","volume":"31","author":"Christopeit","year":"2013","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jtct.2026.06.046_bib0022","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/bmt.2008.255","article-title":"Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant","volume":"42","author":"Shaw","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.06.046_bib0023","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.bmt.1704645","article-title":"Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant","volume":"34","author":"Eapen","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.06.046_bib0024","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2141.2000.02306.x","article-title":"Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation","volume":"111","author":"Guardiola","year":"2000","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.jtct.2026.06.046_bib0025","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.bbmt.2017.07.014","article-title":"Major histocompatibility mismatch and donor choice for second allogeneic bone marrow transplantation","volume":"23","author":"Imus","year":"2017","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.06.046_bib0026","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.humimm.2022.03.001","article-title":"Review: HLA loss and detection in the setting of relapse from HLA-mismatched hematopoietic cell transplant","volume":"83","author":"Arnold","year":"2022","journal-title":"Hum Immunol"},{"issue":"15","key":"10.1016\/j.jtct.2026.06.046_bib0027","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood-2009-11-254284","article-title":"Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation","volume":"115","author":"Villalobos","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2026.06.046_bib0028","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.exphem.2015.02.006","article-title":"Digital PCR to assess hematopoietic chimerism after allogeneic stem cell transplantation","volume":"43","author":"Stahl","year":"2015","journal-title":"Exp Hematol"},{"issue":"14","key":"10.1016\/j.jtct.2026.06.046_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411814","article-title":"Chimerism testing by next generation sequencing for detection of engraftment and early disease relapse in allogeneic hematopoietic cell transplantation and an overview of NGS chimerism studies","volume":"24","author":"Liacini","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.jtct.2026.06.046_bib0030","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/leu.2012.68","article-title":"Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy","volume":"26","author":"Dubois","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.jtct.2026.06.046_bib0031","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/tan.14372","article-title":"Two cases of acute lymphoid leukemia patients with loss of heterozygosity in HLA region before transplantation","volume":"98","author":"Huang","year":"2021","journal-title":"HLA"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726005233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726005233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:19:02Z","timestamp":1793884742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726005233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2666636726005233"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.06.046","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Survey and Next-Generation Sequencing-Based Indel Chimerism Detection of Human Leukocyte Antigens Loss in Relapsed Haploidentical and Mismatched Unrelated Donor Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}